IN8bio Inc (NASDAQ: INAB) is -75.51% lower on its value in year-to-date trading and has touched a low of $0.46 and a high of $2.48 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The INAB stock was last observed hovering at around $0.47 in the last trading session, with the day’s loss setting it -0.13%.
Currently trading at $0.34, the stock is -41.56% and -53.87% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.83 million and changing -27.33% at the moment leaves the stock -68.11% off its SMA200. INAB registered -67.19% loss for a year compared to 6-month loss of -70.62%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -52.61% gain in the last 1 month and extending the period to 3 months gives it a -75.34%, and is -35.64% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.94% over the week and 13.03% over the month.
IN8bio Inc (INAB) has around 31 employees, a market worth around $15.81M and $0.00M in sales. Distance from 52-week low is -26.54% and -86.37% from its 52-week high. The company has generated returns on investments over the last 12 months (-180.18%).
The EPS is expected to grow by 37.50% this year
29.0 institutions hold shares in IN8bio Inc (INAB), with institutional investors hold 44.53% of the company’s shares. The shares outstanding are 43.29M, and float is at 31.74M with Short Float at 0.88%. Institutions hold 34.93% of the Float.
The top institutional shareholder in the company is AIGH CAPITAL MANAGEMENT LLC with over 2.13 million shares valued at $1.8 million. The investor’s holdings represent 4.9157 of the INAB Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 1.42 million shares valued at $1.21 million to account for 3.2892 of the shares outstanding. The other top investors are ENSIGN PEAK ADVISORS, INC which holds 1.12 million shares representing 2.5832 and valued at over $0.95 million, while ALYESKA INVESTMENT GROUP, L.P. holds 1.4807 of the shares totaling 0.64 million with a market value of $0.76 million.
IN8bio Inc (INAB) Insider Activity
The most recent transaction is an insider purchase by Graff Jeremy R., the company’s Director. SEC filings show that Graff Jeremy R. bought 2,500 shares of the company’s common stock on Sep 13 ’23 at a price of $0.95 per share for a total of $2375.0. Following the purchase, the insider now owns 2500.0 shares.
